Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
382
NCT00555451
Safety, Pharmacokinetics and Potential Activity of HE3286 in Obese Adult Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 31, 2007
Completion: Sep 30, 2009
NCT00628433
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
Phase: Phase 1/2
Start: Feb 29, 2008
Completion: May 31, 2009
NCT00694057
Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus
Phase: Phase 2
Start: Jun 30, 2008
Completion: Jan 31, 2010
NCT00712114
Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid Arthritis
Start: Jul 31, 2008
Completion: Jul 31, 2009
NCT00716794
A Phase I/II Study of HE3235 in Patients With Prostate Cancer
Completion: Mar 31, 2011
NCT00991107
A Study of the Safety, Tolerance and Assessment of HE3286 on Insulin Sensitivity and Hepatic Glucose Production
Start: Sep 30, 2009
Completion: Aug 31, 2010